Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10238-012-0227-0PMID 23292294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population

  2012cited by this paper
• Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.

  2012cited by this paper
• Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study.

  2012cited by this paper
• Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials.

  2012cited by this paper
• Growth hormone, dehydroepiandrosterone and adiponectin levels in non‐alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients

  2012cited by this paper
• Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).

  2012cited by this paper
• Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes.

  2012cited by this paper
• The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients

  2012cited by this paper
• Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease

  2011cited by this paper
• Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations.

  2011cited by this paper
• Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

  2011cited by this paper
• Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection

  2011cited by this paper
• Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection

  2011cited by this paper
• Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis.

  2011cited by this paper
• Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m².

  2011cited by this paper
• Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes

  2011cited by this paper
• Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension

  2011cited by this paper
• PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells.

  2011cited by this paper
• Adiponectin Changes in Relation to the Macronutrient Composition of a Weight‐Loss Diet

  2011cited by this paper
• MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.

  2011cited by this paper
• Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

  2010cited by this paper
• The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

  2010cited by this paper
• Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression

  2010cited by this paper
• The Pleiotropic Actions of Adiponectin are Initiated via Receptor-Mediated Activation of Ceramidase Activity

  2010cited by this paper
• Study of adiponectin in chronic liver disease and cholestasis

  2010cited by this paper
• Adipose tissue as an endocrine organ.

  2010cited by this paper
• Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

  2010cited by this paper
• Adiponectin in insulin resistance: lessons from translational research.

  2010cited by this paper
• Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling

  2010cited by this paper
• Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization

  2009cited by this paper
• Systemic Fate of the Adipocyte-Derived Factor Adiponectin

  2009cited by this paper
• Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).

  2009cited by this paper
• Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver disease

  2009cited by this paper
• Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice.

  2009cited by this paper
• Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice.

  2009cited by this paper
• ADIPOHORMONES AS PROGNOSTIC MARKERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

  2009cited by this paper
• NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men

  2008cited by this paper
• Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis

  2008cited by this paper
• Post-translational modifications of adiponectin: mechanisms and functional implications.

  2008cited by this paper
• Adipokines: the missing link between insulin resistance and obesity.

  2008cited by this paper
• The role of adipokines in liver fibrosis.

  2008cited by this paper
• A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

  2008cited by this paper
• Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment

  2008cited by this paper
• Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

  2008cited by this paper
• Adiponectin: A New Independent Predictor of Liver Steatosis and Response to IFN-α Treatment in Chronic Hepatitis C

  2008cited by this paper
• Adipocytokines and liver disease

  2008cited by this paper
• Adipokines and cytokines in non‐alcoholic fatty liver disease

  2007cited by this paper
• Total and High–Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program

  2007cited by this paper
• Total and High–Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program: Comparative Evaluation of Three Assays

  2007cited by this paper
• Usefulness of a Combined Evaluation of the Serum Adiponectin Level, HOMA-IR, and Serum Type IV Collagen 7S Level to Predict the Early Stage of Nonalcoholic Steatohepatitis

  2007cited by this paper
• Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders.

  2007cited by this paper
• Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

  2007cited by this paper
• Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

  2007influential reference
• EFFECTS OF FENOFIBRATE AND XUEZHIKANG ON HIGH‐FAT DIET‐INDUCED NON‐ALCOHOLIC FATTY LIVER DISEASE

  2007cited by this paper
• Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?

  2007cited by this paper
• Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.

  2007cited by this paper
• Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

  2007cited by this paper
• Pathologic assessment of non-alcoholic fatty liver disease.

  2007cited by this paper
• Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists*

  2006cited by this paper
• Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

  2006cited by this paper
• Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

  2006cited by this paper
• Alterations of leptin during IFN-α therapy in patients with chronic viral hepatitis

  2006cited by this paper
• From fat to inflammation.

  2006cited by this paper
• Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.

  2006cited by this paper
• A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

  2006cited by this paper
• Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis.

  2006cited by this paper
• High‐Molecular Weight Adiponectin Isoforms Increase after Biliopancreatic Diversion in Obese Subjects

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

  2006cited by this paper
• Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

  2006cited by this paper
• Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

  2005cited by this paper
• The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology.

  2005cited by this paper
• Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

  2005cited by this paper
• Changes of adiponectin oligomer composition by moderate weight reduction.

  2005cited by this paper
• Adiponectin and adiponectin receptors.

  2005cited by this paper
• Recent concepts in non‐alcoholic fatty liver disease

  2005cited by this paper
• High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.

  2005cited by this paper
• A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

  2005cited by this paper
• Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease

  2005cited by this paper
• Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis

  2005cited by this paper
• Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli.

  2005cited by this paper
• Steatosis: Co‐factor in other liver diseases

  2005cited by this paper
• Review article: hepatitis C virus‐associated steatosis – pathogenic mechanisms and clinical implications

  2005cited by this paper
• Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

  2005cited by this paper
• Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

  2005cited by this paper
• Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator

  2005cited by this paper
• corrigendum: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

  2004cited by this paper
• Adiponectin differentially regulates cytokines in porcine macrophages.

  2004cited by this paper
• Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.

  2004cited by this paper
• Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages

  2004cited by this paper
• Adipose tissue as an endocrine organ.

  2004cited by this paper
• Beyond insulin resistance in NASH: TNF‐α or adiponectin?

  2004cited by this paper
• A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

  2004cited by this paper
• Inverse association between serum adiponectin level and transaminase activities in Japanese male workers.

  2004cited by this paper
• Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.

  2004cited by this paper
• Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity*

  2004cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice.

  2004cited by this paper
• Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.

  2004cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper

• Adiponectin as a Predictor of Metabolic Dysfunction-Associated Steatotic Liver Disease and Non-Alcoholic Fatty Liver Disease: A 17-Year Korean Cohort Study.

  2025cites this paper
• Sex-Specific Effects of Long-Term Antipsychotic Drug Treatment on Adipocyte Tissue and the Crosstalk to Liver and Brain in Rats

  2024cites this paper
• Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease

  2024cites this paper
• Deficiency of Adipose Aryl Hydrocarbon Receptor Protects against Diet-Induced Metabolic Dysfunction through Sexually Dimorphic Mechanisms

  2023cites this paper
• Macrophage metabolism in nonalcoholic fatty liver disease

  2023cites this paper
• Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet

  2023cites this paper
• Innate immunity and nonalcoholic fatty liver disease

  2023influential citation
• Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease

  2022cites this paper
• Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills

  2022cites this paper
• Relationship Of Serum Adiponectin Levels With Glycaemic Status In Pregnant Women.

  2022cites this paper
• Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children.

  2021cites this paper
• Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study

  2021cites this paper
• Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation

  2021influential citation
• Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

  2021cites this paper
• Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation

  2021cites this paper
• The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets

  2021cites this paper
• Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver–Adipose Tissue Crosstalk

  2021cites this paper
• NAFLD and autoimmune hepatitis: Do not judge a book by its cover.

  2020cites this paper
• Organokines in disease.

  2020cites this paper
• The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response

  2020cites this paper
• Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review)

  2020cites this paper
• Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?

  2020cites this paper
• LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2

  2020cites this paper
• Macrophages in the pathophysiology of NAFLD: The role of sex differences

  2020cites this paper
• BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE−/− Mice

  2019cites this paper
• The cytokeratin 18, adiponectin and leptin levels in patients with non-alcoholic steatohepatitis and coronary heart disease

  2019cites this paper
• Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases

  2019cites this paper
• Comparative study of overweight and obese patients with nonalcoholic fatty liver disease.

  2019cites this paper
• First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved

  2019cites this paper
• NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

  2019cites this paper
• Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.

  2019cites this paper
• The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2018cites this paper
• Blood-based novel biomarkers for nonalcoholic steatohepatitis.

  2018cites this paper
• Decreased serum neuregulin 4 levels associated with non‐alcoholic fatty liver disease in children with obesity

  2018cites this paper
• Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study

  2018cites this paper
• The divergent inflammatory and anti-inflammatory effects of adiponectin upon Kupffer cells

  2016cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes

  2016cites this paper
• Innate immune response and non-alcoholic fatty liver disease

  2016cites this paper
• The Role of Sugar-sweetened Water in the Progression of Nonalcoholic Fatty Liver Disease

  2016cites this paper
• The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.

  2016cites this paper
• Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice

  2016cites this paper
• Glycosyltransferases and non-alcoholic fatty liver disease.

  2016cites this paper
• Characteristics of resistin in rheumatoid arthritis angiogenesis.

  2016cites this paper
• Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines

  2016influential citation
• The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease

  2016cites this paper
• Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.

  2016cites this paper
• The role of ADIPOQ methylation in curcumin‐administrated experimental nonalcoholic fatty liver disease

  2016cites this paper
• GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease

  2015cites this paper
• The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case–control study

  2015cites this paper
• The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

  2015cites this paper
• Lactobacillus rhamnosus LA68 and Lactobacillus plantarum WCFS1 differently influence metabolic and immunological parameters in high fat diet-induced hypercholesterolemia and hepatic steatosis.

  2015cites this paper
• Title: Metabolic phenotype and adipose and liver features in the high fat Western diet-induced mouse

  2015cites this paper
• Adiponectin Induces Oncostatin M Expression in Osteoblasts through the PI3K/Akt Signaling Pathway

  2015influential citation
• The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin.

  2015cites this paper
• Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

  2015cites this paper
• Adiponectin polymorphisms and non‐alcoholic fatty liver disease risk: A meta‐analysis

  2014cites this paper
• Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools

  2014cites this paper
• Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis

  2014influential citation
• Adiponectin as a routine clinical biomarker.

  2014cites this paper
• Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis.

  2014cites this paper
• Hepatic Lipid Metabolism and Herbal Impacts on Non-Alcoholic Fatty Liver Disease

  2013cites this paper
• Sex Differences in Serum Leptin and Adiponectin levels in Apparently Healthy Iranian Adults

  2013cites this paper